NCT03826004View on ClinicalTrials.gov

Clemastine in Cardiovascular Surgery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

July 31, 2019

Study Completion Date

January 10, 2020

Conditions
Efficacy and Safety
Interventions
DRUG

Clemastine

Clemastine fumarate 2mg/2ml intramuscular injection is administrated into the gluteus maximus muscle

DRUG

Saline Solution

Saline solution 2ml intramuscular injection is administrated into the gluteus maximus muscle

Trial Locations (1)

100037

Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

NCT03826004 - Clemastine in Cardiovascular Surgery | Biotech Hunter | Biotech Hunter